This inventor holds 1 USPTO granted patent. Top assignee: Jilin University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations of Cuizhu Wang in Anti-Colitis Drug Development
Introduction
Cuizhu Wang is an accomplished inventor based in Changchun, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for inflammatory bowel disease. His innovative work has the potential to improve the quality of life for many patients suffering from colitis.
Latest Patents
Cuizhu Wang holds a patent for the "Use of oleanolic acid-28-O-beta-D-glucopyranoside in preparation of anti-colitis drug." This patent highlights the use of oleanolic acid-28-O-β-D-glucopyranoside, which exhibits significant anti-ulcerative colitis activity compared to its parent compound, oleanolic acid, and other analogues. The efficacy of this compound is comparable to Mesalazine, a first-line treatment for inflammatory bowel disease, while also minimizing the risk of salicylic acid anaphylaxis associated with Mesalazine treatment. This innovation presents a promising application prospect in the pharmaceutical industry.
Career Highlights
Cuizhu Wang is affiliated with Jilin University, where he conducts research and development in the field of medicinal chemistry. His work focuses on creating effective treatments for gastrointestinal disorders, showcasing his dedication to advancing medical science.
Collaborations
Cuizhu Wang collaborates with notable colleagues, including Caixia Wang and Fang Wang. Their combined expertise contributes to the success of their research initiatives and enhances the development of innovative therapeutic solutions.
Conclusion
Cuizhu Wang's contributions to the field of anti-colitis drug development exemplify the impact of innovative research in medicine. His patent on oleanolic acid-28-O-β-D-glucopyranoside represents a significant advancement in treatment options for patients with inflammatory bowel disease.